Anti-interleukin-2 receptor antibodies: basiliximab and daclizumab

Nephrol Dial Transplant. 2001 Sep;16(9):1756-60. doi: 10.1093/ndt/16.9.1756.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Basiliximab
  • Clinical Trials as Topic
  • Daclizumab
  • Dose-Response Relationship, Drug
  • Graft Rejection / prevention & control
  • Humans
  • Immunoglobulin G / administration & dosage
  • Immunoglobulin G / therapeutic use*
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation*
  • Receptors, Interleukin-2 / immunology*
  • Recombinant Fusion Proteins*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Interleukin-2
  • Recombinant Fusion Proteins
  • Basiliximab
  • Daclizumab